Coloplast CEO struggling to find good acquisition candidate

Medtech company Coloplast is still searching high and low for a suitable acquisition to its skin and wound care business. The likelihood of finding something good is not that high at the moment, says the CEO.
Kristian Villumsen, CEO, Coloplast | Photo: Stine Bidstrup/ERH
Kristian Villumsen, CEO, Coloplast | Photo: Stine Bidstrup/ERH
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY CATHERINE BRETT

Coloplast's skin and wound care business is lucrative, but is still too small to live up to its potential - though CEO Kristian Villumsen has plans to change that.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading